Evidence in favour
- 12 distinct acquisition events survive duplicate and security-type controls.
- Participation spans 11 named insiders rather than one filing source.
- The latest qualifying evidence is fresh, dated 03 Aug 2026.
Company insider dossier
Vericel Corp Ord insider intelligence
VCEL filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
62/100
Accumulation bias
92/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Latest evidence
- 3 Aug 2026
Investment committee read
Accumulation bias
Priced common-share acquisitions carry more weighted evidence than disposals after freshness, role, size, and duplicate controls.
Watch for market confirmationDecision risks
- Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Feb 2025Aug 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 45.09 USD
- One-week move
- -1.9%
- Four-week move
- -4.1%
- Fair-value gap
- +7.7%
- Trend signal
- Active
- Relative strength
- 7.2
Directional balance
Controlled event mix
38.7%acquisition
- Acquisition events
- 12
- Disposal events
- 19
- Net value
- -$2.7M
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
025 May
301 Jun
008 Jun
615 Jun
1122 Jun
029 Jun
006 Jul
013 Jul
020 Jul
927 Jul
303 Aug
010 Aug
Named participants
Insider conviction by person
SIEGAL, JONATHANPrincipal Accounting Officer6311 events
HOPPER, JONATHAN MARKChief Medical Officer634 events
HALPIN, MICHAELChief Operating Officer624 events
FLYNN, SEAN C.Chief Legal Officer624 events
MCLAUGHLIN, KEVIN FDirector624 events
HAGEN, HEIDIDirector500 events
RUBINO, ALAN LDirector500 events
WRIGHT, LISADirector500 events
ZERBE, ROBERT L MDDirector500 events
MARA, JOSEPH ANTHONY JRChief Financial Officer252 events
WOTTON, PAUL KDirector252 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable VCEL filing ledger
Showing 61 to 62 of 62.
ZERBE, ROBERT L MDDirector
AcquisitionCommon equity
3200 sharesCommon Stock
Not reportedContext evidence
ZERBE, ROBERT L MDDirector
AcquisitionEquity compensation
3200 sharesRestricted Stock Unit
Not reportedContext evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.